303 related articles for article (PubMed ID: 10974768)
1. [Human immunodeficiency virus and antiretroviral therapy resistance].
Quirós E; Torti C; Carosi G
Enferm Infecc Microbiol Clin; 2000 May; 18(5):234-7. PubMed ID: 10974768
[No Abstract] [Full Text] [Related]
2. Salvage therapy for patients failing their current antiretroviral regimen.
Albrecht MA
AIDS Clin Rev; 2000-2001; ():139-91. PubMed ID: 10999220
[No Abstract] [Full Text] [Related]
3. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.
Recsky MA; Brumme ZL; Chan KJ; Wynhoven B; Yip B; Dong WW; Heath KV; Montaner JS; Levy AR; Hogg RS; Harrigan PR
J Infect Dis; 2004 Jul; 190(2):285-92. PubMed ID: 15216463
[TBL] [Abstract][Full Text] [Related]
4. Genotype and antiretroviral drug resistance of human immunodeficiency virus-1 in Saudi Arabia.
Jamjoom GA; Azhar EI; Madani TA; Hindawi SI; Bakhsh HA; Damanhouri GA
Saudi Med J; 2010 Sep; 31(9):987-92. PubMed ID: 20844809
[TBL] [Abstract][Full Text] [Related]
5. [New trends in HIV].
Volkert R
Dtsch Med Wochenschr; 1998 Sep; 123(38):A7. PubMed ID: 9787287
[No Abstract] [Full Text] [Related]
6. [Resistance to non-nucleoside reverse transcriptase inhibitors].
Casado JL; López JC; Viciana P
Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):30-3. PubMed ID: 11428057
[No Abstract] [Full Text] [Related]
7. [Primary resistance to antiretroviral agents].
Soriano V; María Miró J; Guerrero A
Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):22-5. PubMed ID: 11428054
[No Abstract] [Full Text] [Related]
8. HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?
Uy J; Brooks JT; Baker R; Hoffman M; Moorman A; Novak R;
Antivir Ther; 2007; 12(6):957-62. PubMed ID: 17926650
[TBL] [Abstract][Full Text] [Related]
9. [Resistance to nucleoside reverse transcriptase inhibitors].
Leal M; Santamaría JM
Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):26-9. PubMed ID: 11428055
[No Abstract] [Full Text] [Related]
10. Antiretroviral update: recent advances expand options for patients with HIV.
Santhanam H; Goins M
Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
[No Abstract] [Full Text] [Related]
11. [HIV viral dynamic after antiretroviral treatment initiation: is a rapid decay a good pronostic?].
Delaugerre C
Pathol Biol (Paris); 2010 Dec; 58(6):403-5. PubMed ID: 19481371
[No Abstract] [Full Text] [Related]
12. Antiretroviral therapy: where are we?
Hammer SM; Yeni P
AIDS; 1998; 12 Suppl A():S181-8. PubMed ID: 9633001
[No Abstract] [Full Text] [Related]
13. Primary drug resistance in antiretroviral-naïve injection drug users.
Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
[TBL] [Abstract][Full Text] [Related]
14. Viral resistance: a major challenge in managing HIV disease.
Boucher CA; Reedijk M
J Biol Regul Homeost Agents; 1995; 9(3):91-4. PubMed ID: 8782014
[No Abstract] [Full Text] [Related]
15. Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy.
Hanna GJ; D'Aquila RT
Clin Infect Dis; 2001 Mar; 32(5):774-82. PubMed ID: 11229846
[TBL] [Abstract][Full Text] [Related]
16. [Drug resistance in antiretroviral therapy of HIV infection].
Oette M; Häussinger D
Med Klin (Munich); 2003 Dec; 98(12):692-9. PubMed ID: 14685670
[TBL] [Abstract][Full Text] [Related]
17. HIV resistance testing proves its value.
Proj Inf Perspect; 1999 Sep; (28):14. PubMed ID: 11367356
[TBL] [Abstract][Full Text] [Related]
18. Antiviral treatment of HIV infection.
Thomas MG; Ellis-Pegler RB
N Z Med J; 1998 Sep; 111(1074):353-4. PubMed ID: 11039818
[No Abstract] [Full Text] [Related]
19. Pharmacoresistance: an emerging clinical problem.
Carosi G
J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):9-14. PubMed ID: 9689572
[No Abstract] [Full Text] [Related]
20. Guide to major clinical trials of antiretroviral therapy in human immunodeficiency virus-infected patients: protease inhibitors, non-nucleoside reverse transcriptase inhibitors, and nucleotide reverse transcriptase inhibitors.
Tavel JA; Miller KD; Masur H
Clin Infect Dis; 1999 Mar; 28(3):643-76. PubMed ID: 10194094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
